Lepu Biopharma Co., Ltd. (2157.HK) HKSE
Currency In HKD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 7.83B |
| Enterprise Value | 8.04B |
| P/E Ratio | 25.04 |
| PEG Ratio | 0.11 |
| Price/Sales Ratio | 6.25 |
| Price/Book Ratio | 4.32 |
| Enterprise/Revenue | 6.28 |
| Enterprise/EBITDA | 54.04 |
Fiscal Year
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | June 30, 2026 |
Profitability
| Profit Margin | 0.25 |
| Operating Margin | 0.07 |
AD
Management Effectiveness
| Return On Assets | 0.08 |
| Return On Equity | 0.17 |
Income Statement
| Revenue | 910.67M |
| Revenue/Share | 0.54 |
| Gross Profit | 732.1M |
| EBITDA | 178.73M |
| Net Income | 254.6M |
| Diluted EPS | 0.14 |
Balance Sheet
| Total Cash | 788.84M |
| Total Cash/Share | 0.44 |
| Total Debt | 714.75M |
| Total Debt/Equity | 0.51 |
| Current Ratio | 1.14 |
| Book Value Per Share | 0.78 |
Price History
| 52-Week Change | -61.2 |
| 52-Week High | 10.5 |
| 52-Week Low | 3.55 |
| Moving Average 50 Days | 4.27 |
| Moving Average 200 Days | 4.93 |
Statistics
| Average Volume | 9.58M |
| Shares Outstanding | 1.8B |
| % Held by Institutions | N/A |
Dividend And Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | N/A |
| Last Split Date | N/A |
AD
